Treatment for Body Dysmorphic Disorder

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Body Dysmorphic Disorder
Eligibility
18 - 90
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test new sequences on patients and healthy volunteers.

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 5 years

5 years
Conduct clinical protocol development and validation
Demonstrate and train

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

0 Treatment Group

2000 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,448 Previous Clinical Trials
773,899 Total Patients Enrolled

Eligibility Criteria

Age 18 - 90 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
• Age at least 18 years.
You have a GFR ≥30 ml/min.
When contrast is being administered: healthy volunteers with a GFR≥60 ml/min.